Experimental and Translational Ophthalmology connects fundamental discoveries in ocular biology with the development of new diagnostic and therapeutic approaches. The session encompasses experimental disease models, cellular and molecular mechanisms, preclinical studies, therapeutic targets, translational research, and pathways that move discoveries from laboratory investigation toward clinical application.
Abstract Scope and Participation
Submissions may include basic science, cellular and molecular studies, experimental models, preclinical research, therapeutic development, translational methods, and proof-of-concept investigators. Basic scientists, ophthalmologists, biomedical researchers, translational investigators, pharmacologists, and interdisciplinary research teams are invited to participate.







Title : Why a paediatric orthoptic oncology service matters
Shenika Tailor, University Hospitals of Leicester NHS Trust, United Kingdom
Title : Stereotactic radiotherapy for wet age-related macular degeneration: year 4 results of a randomised, double-masked, sham-controlled trial
Tim Jackson, King’s College London, United Kingdom